Education
About Us
Working with TipRanks
Follow Us
SIGA Technologies Inc (SIGA)
NASDAQ:SIGA
SIGA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$4.95 - $9.62
Previous CloseN/A
Volume59.56K
Average Volume (3M)630.79K
Market Cap
$644.45M
Enterprise Value$286.41M
Total Cash (Recent Filing)$182.46M
Total Debt (Recent Filing)$570.43K
Price to Earnings (P/E)7.8
Beta1.11
Next Earnings
Nov 06, 2025EPS EstimateN/A
Last Dividend Ex-Date
Apr 29, 2025Dividend Yield10.13%
Share Statistics
EPS (TTM)0.49
Shares Outstanding71,606,000
10 Day Avg. Volume556,344
30 Day Avg. Volume630,786
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.44
Enterprise Value/Revenue1.59
Enterprise Value/Gross Profit2.18
Enterprise Value/Ebitda2.78
Forecast
1Y Price Target
$8.50Price Target Upside-1.85% Downside
Rating ConsensusModerate Buy
Number of Analyst Covering0
SIGA Technologies News
SIGA FAQ
What was SIGA Technologies Inc’s price range in the past 12 months?
SIGA Technologies Inc lowest stock price was $4.95 and its highest was $9.62 in the past 12 months.
What is SIGA Technologies Inc’s market cap?
SIGA Technologies Inc’s market cap is $644.45M.
When is SIGA Technologies Inc’s upcoming earnings report date?
SIGA Technologies Inc’s upcoming earnings report date is Nov 06, 2025 which is in 49 days.
How were SIGA Technologies Inc’s earnings last quarter?
SIGA Technologies Inc released its earnings results on Aug 05, 2025. The company reported $0.49 earnings per share for the quarter, beating the consensus estimate of N/A by $0.49.
Is SIGA Technologies Inc overvalued?
According to Wall Street analysts SIGA Technologies Inc’s price is currently Overvalued.
Does SIGA Technologies Inc pay dividends?
SIGA Technologies Inc pays a Notavailable dividend of $0.6 which represents an annual dividend yield of 10.13%. See more information on SIGA Technologies Inc dividends here
What is SIGA Technologies Inc’s EPS estimate?
SIGA Technologies Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SIGA Technologies Inc have?
SIGA Technologies Inc has 71,606,000 shares outstanding.
What happened to SIGA Technologies Inc’s price movement after its last earnings report?
SIGA Technologies Inc reported an EPS of $0.49 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 10%.
Which hedge fund is a major shareholder of SIGA Technologies Inc?
Currently, no hedge funds are holding shares in SIGA
SIGA Technologies Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.50 (-1.85% Downside)
$8.50 (-1.85% Downside)
Blogger Sentiment
Bullish
SIGA Sentiment 100%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Decreased
By 1.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.5%
Last 30 Days ▼ 2.8%
Last 30 Days ▼ 2.8%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.25%
12-Months-Change
Fundamentals
Return on Equity
43.61%
Trailing 12-Months
Asset Growth
22.15%
Trailing 12-Months
Company Description
SIGA Technologies Inc
SIGA Technologies, Inc. is a biotechnology company focused on developing and commercializing novel solutions for serious diseases, particularly those caused by bioterrorism and infectious diseases. The company operates primarily within the pharmaceutical sector and is known for its lead product, TPOXX (tecovirimat), which is an antiviral treatment approved for the treatment of smallpox. SIGA is also involved in research and development efforts to expand its pipeline of antiviral therapeutics.
SIGA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong product revenues, increased government funding, and a solid financial position, indicating robust performance and growth potential. However, regulatory challenges in Europe concerning tecovirimat's efficacy in treating mpox present a potential hurdle in international markets.View all SIGA earnings summariesTechnical Analysis
Emergent Biosolutions
―
Evotec AG
―
Organogenesis Holdings
―
Aquestive Therapeutics
―
Regencell Bioscience
―
Ownership Overview
1.50% Insiders
14.21% Mutual Funds
16.31% Other Institutional Investors
58.15% Public Companies and
Individual Investors